NeurologyLive® Year in Review 2022: Most-Watched Video Series Episodes

The NeurologyLive^® team put together more than 25 highly produced and engaging video series, each featuring experts in patient care, advocacy, and clinical trials discussing the hottest topics driving the conversations in their respective fields and specialties.

In 2022, there were hundreds of episodes posted from Cure Connections^®, Insights^®, Peers & Perspectives^®, Peer Exchange™, and News Network series, each focusing on key aspects of neurologic medicine. From rare epilepsies to insomnia, multiple sclerosis, myasthenia gravis, and more, these programs brought together thought leaders and expert clinicians from all over the world to share their experiences and answer the burning questions in research and care.

Here, we'll highlight the most-viewed episodes on NeurologyLive^® this year. Click the buttons to watch more from the series they are featured in.

1. The DISCO-MS Study Findings and Clinical Experience

In episode 6 of the "Consortium of MS Centers 2022: News Network" series, Robert Fox, MD, offered perspective on data from the DISCO-MS study of disease-modifying therapy discontinuation in patients with multiple sclerosis and how it compares with day-to-day clinical practice. WATCH TIME: 5 minutes

2. BTK Inhibitors and Novel Approaches to Multiple Sclerosis

In episode 4 of the "American Academy of Neurology 2022: Multiple Sclerosis Highlights" series, Robert K. Shin, MD, offered his perspective on the novel therapies being developed for multiple sclerosis, highlighting the potential of Bruton tyrosine kinase inhibitors for progressive disease. WATCH TIME: 4 minutes

3. Elucidating the Association of Epstein-Barr Virus and Multiple Sclerosis

In episode 1 of the "Demystifying Multiple Sclerosis Etiology: The Role of Epstein-Barr Virus" series, Scott Newsome, DO, leads a panel discussion with thought leaders on the implications of findings from a recently published longitudinal study drawing a causal link between Epstein-Barr virus and multiple sclerosis. WATCH TIME: 20 minutes

4. Drugs to Avoid in Patients With Myasthenia Gravis

In episode 8 of the "Updates in the Management of Myasthenia Gravis Peers and Perspectives" series, James F. Howard Jr., MD, and Nicholas J. Silvestri, MD, FAAN, offer a comprehensive review of drugs to avoid when designing treatment plans for patients with myasthenia gravis. WATCH TIME: 3 minutes

5. Unmet Needs in the Management of Insomnia

In episode 14 of the "Unmet Needs in Treating Insomnia" series, Nathaniel Fletcher Watson, MD, and Vikas Jain, MD, FAASM, FAAFP, CCSH, CPE, give a brief review of the unmet needs in insomnia management, particularly access to treatment and daytime functioning. WATCH TIME: 9 minutes

6. Differentiating Migraine From Other Headache Disorders

In episode 4 of the "Optimal Management of Acute and Preventive Migraine" series, Jessica Ailani, MD, and Bradley Torphy, MD, discern the signs of migraine and comment on the importance of ensuring accurate diagnosis for patients. WATCH TIME: 4 minutes

7. Impact of Narcolepsy on Quality of Life

In episode 2 of the "Improving Diagnosis and Patient Outcomes in Narcolepsy" series, Russell Rosenberg, PhD, DABSM, and Margaret Park, MD, evaluate the impact of narcolepsy on a patient’s quality of life and expand on which symptoms appear to be most debilitating. WATCH TIME: 6 minutes

8. AAN Expert Exchange: Sphingosine-1 Phosphate Modulation in MS

In episode 3 of the "AAN Expert Exchange" series, Barry Hendin, MD; Regina Berkovich, MD, PhD; and Ahmed Obeidat, MD, PhD, exchange their thoughts on the use of the sphingosine-1 phosphate modulating class of medicines in treating the disease. WATCH TIME: 4 minutes

9. The Induction vs Escalation Approach to MS and the TREAT-MS Trial

Scott Newsome, DO, and Ellen Mowry, MD, discuss the ongoing TREAT-MS trial and its goals, the importance of the findings for clinical practice in multiple sclerosis, and the ongoing discussion around induction vs escalation in MS treatment. WATCH TIME: 24 minutes

10. Unmet Needs and the Future of Treatment for AD

In episode 6 of the "Advances in the Testing and Treatment of Alzheimer’s Disease" series, Jeffrey L. Cummings, MD, ScD, comments on the unmet needs and future outlook for the Alzheimer’s treatment landscape. WATCH TIME: 2 minutes